A case report of combination treatment with potassium-titanyl phosphate laser and brimonidine topical gel in erythematotelangiectatic rosacea. (19th May 2017)

• Record Type: Journal Article
• Authors: Hofmann, Maja A.; Kokolakis, G.
• Is Part Of: Journal of cosmetic and laser therapy. Volume 19:Number 4(2017:Aug.)
• Page Start: 222
• Page End: 224
• Publication Date: 2017-05-19
• Subjects: Brimonidine gel -- KTP laser therapy -- persistent erythema -- rosacea; Skin -- Laser surgery -- Periodicals; Surgery, Plastic -- Periodicals; 617.477
• DOI: 10.1080/14764172.2017.1279334
• Languages: English
• ISSNs: 1476-4172

Abstract

ABSTRACT: Laser therapies have been shown to provide symptom improvement in patients with erythema and telangiectasia of rosacea; however, they are associated with side effects such as erythema. Combinatorial treatment with pharmacological agents and laser have demonstrated better efficacy, fewer side effects and continued long-term remission compared with monotherapies. A case of moderate facial erythema that responded well to combination treatment with brimonidine 3 mg/g gel and a treatment course of potassium-titanyl phosphate (KTP) laser therapy is presented, showing a reduction from baseline, maintained after final laser session, by applying brimonidine 3 mg/g gel daily. Using brimonidine 3 mg/g gel to target post-laser treatment erythema is highly effective in minimising refractory erythema. Continued use of brimonidine 3 mg/g gel provides a sustained reduction of erythema, increasing the visibility of other signs and symptoms of rosacea that may be present. This can facilitate the treatment of these additional signs and symptoms.